| 0 |
INTRACRANIAL CALCIFICATION |
2 |
0.0541 |
| 1 |
HYPOCALCAEMIC SEIZURE |
1 |
0.0133 |
| 2 |
DECOMPENSATED HYPOTHYROIDISM |
1 |
0.0074 |
| 3 |
URINE CALCIUM INCREASED |
2 |
0.0063 |
| 4 |
HYPERCALCIURIA |
3 |
0.0061 |
| 5 |
RICKETS |
1 |
0.0053 |
| 6 |
PRODUCT CONTAMINATION WITH BODY FLUID |
1 |
0.0049 |
| 7 |
POST PROCEDURAL HYPOTHYROIDISM |
1 |
0.0047 |
| 8 |
EXTRASKELETAL OSSIFICATION |
1 |
0.0047 |
| 9 |
HYPOCALCAEMIA |
85 |
0.0045 |
| 10 |
BLOOD CALCIUM ABNORMAL |
7 |
0.0042 |
| 11 |
HYPERCALCAEMIA |
51 |
0.0041 |
| 12 |
HYPERCALCAEMIA OF MALIGNANCY |
1 |
0.0037 |
| 13 |
INTENTIONAL DEVICE USE ISSUE |
3 |
0.0035 |
| 14 |
TETANY |
6 |
0.0033 |
| 15 |
GASTROENTERITIS ROTAVIRUS |
1 |
0.0032 |
| 16 |
TACHYPHYLAXIS |
1 |
0.0029 |
| 17 |
BLOOD CALCIUM DECREASED |
28 |
0.0025 |
| 18 |
INVASIVE BREAST CARCINOMA |
1 |
0.0024 |
| 19 |
MULTIPLE ACYL-COENZYME A DEHYDROGENASE DEFICIENCY |
1 |
0.0023 |
| 20 |
SOFT TISSUE MASS |
1 |
0.0022 |
| 21 |
MORNING SICKNESS |
1 |
0.0018 |
| 22 |
RECALLED PRODUCT |
3 |
0.0017 |
| 23 |
ACIDOSIS HYPERCHLORAEMIC |
1 |
0.0017 |
| 24 |
SACRAL PAIN |
1 |
0.0016 |
| 25 |
FRACTURED SACRUM |
2 |
0.0016 |
| 26 |
BLOOD CALCIUM INCREASED |
14 |
0.0016 |
| 27 |
THIRST DECREASED |
1 |
0.0016 |
| 28 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 29 |
GRANULOMA ANNULARE |
1 |
0.0014 |
| 30 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
2 |
0.0013 |
| 31 |
PRODUCT KNOWLEDGE DEFICIT |
1 |
0.0013 |
| 32 |
LIP ERYTHEMA |
1 |
0.0013 |
| 33 |
NON-SMALL CELL LUNG CANCER METASTATIC |
1 |
0.0011 |
| 34 |
BLOOD UREA ABNORMAL |
1 |
0.0011 |
| 35 |
THYROID HORMONES INCREASED |
1 |
0.0010 |
| 36 |
KETOSIS |
1 |
0.0009 |
| 37 |
NEPHROCALCINOSIS |
1 |
0.0008 |
| 38 |
CALCIUM DEFICIENCY |
1 |
0.0008 |
| 39 |
BILIARY OBSTRUCTION |
1 |
0.0008 |
| 40 |
BODY MASS INDEX INCREASED |
1 |
0.0007 |
| 41 |
BLOOD PHOSPHORUS INCREASED |
2 |
0.0007 |
| 42 |
CORNEAL ABRASION |
1 |
0.0007 |
| 43 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 44 |
VITAMIN D DECREASED |
6 |
0.0007 |
| 45 |
BRAIN FOG |
11 |
0.0007 |
| 46 |
HAEMORRHAGE IN PREGNANCY |
1 |
0.0007 |
| 47 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 48 |
CHOLANGIOCARCINOMA |
1 |
0.0007 |
| 49 |
ANTIBODY TEST POSITIVE |
1 |
0.0006 |
| 50 |
INJECTION SITE REACTION |
40 |
0.0006 |
| 51 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 52 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 53 |
BLOOD PHOSPHORUS DECREASED |
2 |
0.0005 |
| 54 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 55 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 56 |
TUNNEL VISION |
1 |
0.0005 |
| 57 |
HYPOGLYCAEMIC UNCONSCIOUSNESS |
1 |
0.0005 |
| 58 |
PHOTOPSIA |
3 |
0.0005 |
| 59 |
SPINAL COLUMN INJURY |
1 |
0.0004 |
| 60 |
LUMBAR VERTEBRAL FRACTURE |
2 |
0.0004 |
| 61 |
URINARY TRACT OBSTRUCTION |
1 |
0.0004 |
| 62 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
19 |
0.0004 |
| 63 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 64 |
URINE OUTPUT INCREASED |
1 |
0.0004 |
| 65 |
INJECTION SITE DISCHARGE |
2 |
0.0004 |
| 66 |
JOINT LOCK |
1 |
0.0004 |
| 67 |
PRODUCT AVAILABILITY ISSUE |
8 |
0.0004 |
| 68 |
MASTICATION DISORDER |
1 |
0.0003 |
| 69 |
BLEPHAROSPASM |
2 |
0.0003 |
| 70 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 71 |
SUSPECTED COVID-19 |
1 |
0.0003 |
| 72 |
NEPHRITIS |
1 |
0.0003 |
| 73 |
THROMBOPHLEBITIS |
1 |
0.0003 |
| 74 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 75 |
SKIN WEEPING |
1 |
0.0003 |
| 76 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 77 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 78 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 79 |
MUSCLE TWITCHING |
6 |
0.0003 |
| 80 |
INJECTION SITE URTICARIA |
6 |
0.0002 |
| 81 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 82 |
HEPATIC PAIN |
1 |
0.0002 |
| 83 |
CHAPPED LIPS |
1 |
0.0002 |
| 84 |
IRON DEFICIENCY |
1 |
0.0002 |
| 85 |
APPENDICITIS |
2 |
0.0002 |
| 86 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 87 |
KIDNEY TRANSPLANT REJECTION |
1 |
0.0002 |
| 88 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 89 |
NEEDLE ISSUE |
6 |
0.0002 |
| 90 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 91 |
DEVICE USE ERROR |
7 |
0.0002 |
| 92 |
DRUG DELIVERY SYSTEM MALFUNCTION |
1 |
0.0002 |
| 93 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 94 |
STRESS FRACTURE |
1 |
0.0002 |
| 95 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 96 |
ORTHOSTATIC HYPOTENSION |
3 |
0.0002 |
| 97 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 98 |
ENERGY INCREASED |
1 |
0.0002 |
| 99 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 100 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 101 |
SCOLIOSIS |
1 |
0.0002 |
| 102 |
OLIGURIA |
1 |
0.0002 |
| 103 |
SWELLING OF EYELID |
1 |
0.0002 |
| 104 |
WALKING AID USER |
1 |
0.0002 |
| 105 |
SPINAL FRACTURE |
3 |
0.0001 |
| 106 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 107 |
TASTE DISORDER |
3 |
0.0001 |
| 108 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 109 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 110 |
EXTRASYSTOLES |
1 |
0.0001 |
| 111 |
INTENTIONAL DOSE OMISSION |
4 |
0.0001 |
| 112 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 113 |
PARAESTHESIA |
21 |
0.0001 |
| 114 |
OSTEOPENIA |
2 |
0.0001 |
| 115 |
TRANSPLANT REJECTION |
1 |
0.0001 |
| 116 |
POLYURIA |
1 |
0.0001 |
| 117 |
HYPERAESTHESIA |
1 |
0.0001 |
| 118 |
BONE PAIN |
7 |
0.0001 |
| 119 |
PERICARDITIS |
2 |
0.0001 |
| 120 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 121 |
DEVICE DEFECTIVE |
2 |
0.0001 |
| 122 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
3 |
0.0001 |
| 123 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 124 |
MATERNAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 125 |
THERAPY INTERRUPTED |
8 |
0.0001 |
| 126 |
THIRST |
2 |
0.0001 |
| 127 |
LIMB INJURY |
3 |
0.0001 |
| 128 |
NEPHROLITHIASIS |
5 |
0.0001 |
| 129 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 130 |
UROSEPSIS |
1 |
0.0001 |
| 131 |
NERVE COMPRESSION |
1 |
0.0001 |
| 132 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 133 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 134 |
ORAL HERPES |
2 |
0.0001 |
| 135 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 136 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 137 |
HYPOTONIA |
1 |
0.0001 |
| 138 |
BRAIN INJURY |
1 |
0.0001 |
| 139 |
INJURY ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 140 |
POLLAKIURIA |
4 |
0.0001 |
| 141 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 142 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 143 |
HEAD INJURY |
3 |
0.0001 |
| 144 |
NIGHT SWEATS |
3 |
0.0001 |
| 145 |
SKIN LACERATION |
1 |
0.0001 |
| 146 |
OESOPHAGITIS |
1 |
0.0001 |
| 147 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 148 |
VIRAL INFECTION |
3 |
0.0001 |
| 149 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 150 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 151 |
MICTURITION URGENCY |
1 |
0.0001 |
| 152 |
NEOPLASM |
1 |
0.0001 |
| 153 |
HYPOAESTHESIA |
13 |
0.0001 |
| 154 |
SPINAL PAIN |
1 |
0.0001 |
| 155 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 156 |
THYROID CANCER |
1 |
0.0001 |
| 157 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 158 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 159 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 160 |
DEVICE DIFFICULT TO USE |
5 |
0.0001 |
| 161 |
ABORTION SPONTANEOUS |
3 |
0.0001 |
| 162 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 163 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 164 |
HUNGER |
1 |
0.0001 |
| 165 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 166 |
MASS |
1 |
0.0001 |
| 167 |
SKIN REACTION |
1 |
0.0001 |
| 168 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 169 |
BRONCHOSPASM |
1 |
0.0001 |
| 170 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 171 |
ANGINA PECTORIS |
2 |
0.0001 |
| 172 |
PALPITATIONS |
8 |
0.0001 |
| 173 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 174 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 175 |
MUSCLE SPASMS |
12 |
0.0001 |
| 176 |
HYPOKALAEMIA |
3 |
0.0001 |
| 177 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 178 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 179 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 180 |
SEIZURE |
7 |
0.0001 |
| 181 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 182 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |
| 183 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 184 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 185 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 186 |
RASH PRURITIC |
3 |
0.0001 |
| 187 |
TOOTHACHE |
1 |
0.0001 |
| 188 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 189 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 190 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 191 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 192 |
FRACTURE |
1 |
0.0001 |
| 193 |
FEELING JITTERY |
1 |
0.0001 |
| 194 |
LETHARGY |
3 |
0.0001 |
| 195 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 196 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 197 |
ERUCTATION |
1 |
0.0001 |
| 198 |
BACK PAIN |
12 |
0.0001 |
| 199 |
KIDNEY INFECTION |
1 |
0.0001 |
| 200 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 201 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 202 |
SYNCOPE |
5 |
0.0000 |
| 203 |
DRY MOUTH |
4 |
0.0000 |
| 204 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 205 |
OSTEOPOROSIS |
2 |
0.0000 |
| 206 |
TOOTH LOSS |
1 |
0.0000 |
| 207 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 208 |
MOUTH ULCERATION |
1 |
0.0000 |
| 209 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 210 |
DIZZINESS |
23 |
0.0000 |
| 211 |
SWELLING FACE |
3 |
0.0000 |
| 212 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 213 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 214 |
TINNITUS |
2 |
0.0000 |
| 215 |
HEADACHE |
27 |
0.0000 |
| 216 |
COMA |
2 |
0.0000 |
| 217 |
MIGRAINE |
4 |
0.0000 |
| 218 |
URTICARIA |
7 |
0.0000 |
| 219 |
NEURALGIA |
1 |
0.0000 |
| 220 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 221 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 222 |
NAUSEA |
31 |
0.0000 |
| 223 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 224 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 225 |
SKIN ULCER |
1 |
0.0000 |
| 226 |
SPEECH DISORDER |
2 |
0.0000 |
| 227 |
GASTRITIS |
1 |
0.0000 |
| 228 |
CARDIAC FAILURE |
3 |
0.0000 |
| 229 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 230 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 231 |
DIVERTICULITIS |
1 |
0.0000 |
| 232 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 233 |
HAEMOPTYSIS |
1 |
0.0000 |
| 234 |
EYE PAIN |
2 |
0.0000 |
| 235 |
PAIN IN JAW |
1 |
0.0000 |
| 236 |
DECREASED APPETITE |
8 |
0.0000 |
| 237 |
DYSSTASIA |
1 |
0.0000 |
| 238 |
PAIN IN EXTREMITY |
10 |
0.0000 |
| 239 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 240 |
CATARACT |
2 |
0.0000 |
| 241 |
DEVICE ISSUE |
3 |
0.0000 |
| 242 |
APHASIA |
1 |
0.0000 |
| 243 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 244 |
DISCOMFORT |
2 |
0.0000 |
| 245 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 246 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 247 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 248 |
ASTHENIA |
12 |
0.0000 |
| 249 |
VOMITING |
15 |
0.0000 |
| 250 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 251 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 252 |
ARTHRALGIA |
13 |
0.0000 |
| 253 |
HIP FRACTURE |
1 |
0.0000 |
| 254 |
OSTEONECROSIS |
1 |
0.0000 |
| 255 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 256 |
URINARY RETENTION |
1 |
0.0000 |
| 257 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 258 |
MYALGIA |
5 |
0.0000 |
| 259 |
SINUSITIS |
3 |
0.0000 |
| 260 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 261 |
BURNING SENSATION |
2 |
0.0000 |
| 262 |
FATIGUE |
22 |
0.0000 |
| 263 |
MOBILITY DECREASED |
2 |
0.0000 |
| 264 |
PANIC ATTACK |
1 |
0.0000 |
| 265 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 266 |
INFLUENZA |
3 |
0.0000 |
| 267 |
DYSARTHRIA |
1 |
0.0000 |
| 268 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 269 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 270 |
THROMBOSIS |
2 |
0.0000 |
| 271 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 272 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 273 |
FALL |
8 |
0.0000 |
| 274 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 275 |
HYPERTENSION |
5 |
0.0000 |
| 276 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 277 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 278 |
HYPOACUSIS |
1 |
0.0000 |
| 279 |
BALANCE DISORDER |
2 |
0.0000 |
| 280 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 281 |
MENTAL DISORDER |
1 |
0.0000 |
| 282 |
RENAL FAILURE |
3 |
0.0000 |
| 283 |
LIVER DISORDER |
1 |
0.0000 |
| 284 |
TACHYCARDIA |
2 |
0.0000 |
| 285 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 286 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 287 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 288 |
DIARRHOEA |
14 |
0.0000 |
| 289 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 290 |
WEIGHT DECREASED |
6 |
0.0000 |
| 291 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 292 |
ARRHYTHMIA |
1 |
0.0000 |
| 293 |
DYSPHAGIA |
2 |
0.0000 |
| 294 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 295 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 296 |
FEELING ABNORMAL |
5 |
0.0000 |
| 297 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 298 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 299 |
PRURITUS |
8 |
0.0000 |
| 300 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 301 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 302 |
MALAISE |
9 |
0.0000 |
| 303 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 304 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 305 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 306 |
ECZEMA |
1 |
0.0000 |
| 307 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 308 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 309 |
TREMOR |
3 |
0.0000 |
| 310 |
ARTHROPATHY |
1 |
0.0000 |
| 311 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 312 |
ASTHMA |
2 |
0.0000 |
| 313 |
ANXIETY |
5 |
0.0000 |
| 314 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 315 |
IRRITABILITY |
1 |
0.0000 |
| 316 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 317 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 318 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 319 |
VERTIGO |
1 |
0.0000 |
| 320 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 321 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 322 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 323 |
DEHYDRATION |
2 |
0.0000 |
| 324 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 325 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 326 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 327 |
ERYTHEMA |
3 |
0.0000 |
| 328 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 329 |
SLEEP DISORDER |
1 |
0.0000 |
| 330 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 331 |
CONSTIPATION |
3 |
0.0000 |
| 332 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 333 |
OFF LABEL USE |
12 |
0.0000 |
| 334 |
UNDERDOSE |
1 |
0.0000 |
| 335 |
AGITATION |
1 |
0.0000 |
| 336 |
BRONCHITIS |
1 |
0.0000 |
| 337 |
DYSGEUSIA |
1 |
0.0000 |
| 338 |
HOT FLUSH |
1 |
0.0000 |
| 339 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 340 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 341 |
DRUG INTERACTION |
2 |
0.0000 |
| 342 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 343 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 344 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 345 |
RASH |
5 |
0.0000 |
| 346 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 347 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 348 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 349 |
INSOMNIA |
3 |
0.0000 |
| 350 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 351 |
BREAST CANCER |
1 |
0.0000 |
| 352 |
COUGH |
3 |
0.0000 |
| 353 |
DYSPNOEA |
6 |
0.0000 |
| 354 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 355 |
CONTUSION |
1 |
0.0000 |
| 356 |
ALOPECIA |
2 |
0.0000 |
| 357 |
HEART RATE INCREASED |
1 |
0.0000 |
| 358 |
HYPOTENSION |
2 |
0.0000 |
| 359 |
SOMNOLENCE |
2 |
0.0000 |
| 360 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 361 |
FLUSHING |
1 |
0.0000 |
| 362 |
PAIN |
6 |
0.0000 |
| 363 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 364 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 365 |
ILLNESS |
1 |
0.0000 |
| 366 |
PNEUMONIA |
3 |
0.0000 |
| 367 |
WEIGHT INCREASED |
2 |
0.0000 |
| 368 |
DEPRESSION |
2 |
0.0000 |
| 369 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 370 |
CHILLS |
1 |
0.0000 |
| 371 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 372 |
HYPERHIDROSIS |
1 |
0.0000 |
| 373 |
DRY SKIN |
1 |
0.0000 |
| 374 |
VISION BLURRED |
1 |
0.0000 |
| 375 |
DRUG INEFFECTIVE |
9 |
0.0000 |
| 376 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 377 |
COVID-19 |
1 |
0.0000 |
| 378 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 379 |
CHEST PAIN |
1 |
0.0000 |
| 380 |
ANAEMIA |
1 |
0.0000 |
| 381 |
OVERDOSE |
1 |
0.0000 |